Richard Heller
Impact in
- Biotechnology top 0.01%
- Microbial Inactivation Methods
- Transgenic Plants and Applications
- Immunology top 0.5%
- Toxin Mechanisms and Immunotoxins
- Immunotherapy and Immune Responses
Papers in
- Biotechnology 118
- Microbial Inactivation Methods 118
- Transgenic Plants and Applications 49
- Immunology 46
- Toxin Mechanisms and Immunotoxins 34
- Immunotherapy and Immune Responses 10
- Co-authors
- Mark J. JaroszeskiLoreé C. HellerRichard GilbertDomenico CoppolaRichard JoveHua YuRonald C. DeContiM. L. Lucas
- Journals
- Bioelectrochemistry (10 papers)Gene Therapy (7 papers)Molecular Therapy (6 papers)Technology in Cancer Research & Treatment (5 papers)Plasma Chemistry and Plasma Processing (4 papers)
- Partner nations
- United StatesSloveniaFrance
In The Last Decade
Richard Heller
167 papers receiving 10.4k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Biotechnology 5.1k
- Immunology 3.0k
- Oncology 3.0k
- Physiology 381
- Biomedical Engineering 3.2k
Countries citing papers authored by Richard Heller
This map shows the geographic impact of Richard Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Heller more than expected).
Fields of papers citing papers by Richard Heller
This network shows the impact of papers produced by Richard Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Heller. The network helps show where Richard Heller may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard Heller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 12 | |
| 3 | 2021 | 1 | |
| 4 | 2020 | 7 | |
| 5 | 2019 | 70 | |
| 6 | 2018 | 0 | |
| 7 | 2014 | 11 | |
| 8 | 2009 | 47 | |
| 9 | Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma Hit paper breakdown → | 2008 | 503 |
| 10 | Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells Hit paper breakdown → | 2003 | 923 |
| 11 | Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Hit paper breakdown → | 2002 | 1019 |
| 12 | 2002 | 204 | |
| 13 | 2001 | 26 | |
| 14 | 2001 | 60 | |
| 15 | 2001 | 16 | |
| 16 | 2000 | 55 | |
| 17 | 1998 | 356 | |
| 18 | Maladie des griffes du chat et infections associées | 1997 | 1 |
| 19 | 1995 | 10 | |
| 20 | 1994 | 220 |
About Richard Heller
Richard Heller is a scholar working on Biotechnology, Immunology, Biomedical Engineering, Molecular Biology and Oncology, having authored 171 papers that have together received 10.7k indexed citations. Recurring topics across this work include Microbial Inactivation Methods (118 papers), Transgenic Plants and Applications (49 papers), Microfluidic and Bio-sensing Technologies (47 papers), Toxin Mechanisms and Immunotoxins (34 papers), Viral Infectious Diseases and Gene Expression in Insects (28 papers), Plasma Applications and Diagnostics (11 papers), Immunotherapy and Immune Responses (10 papers) and 3D Printing in Biomedical Research (10 papers). The work is most often cited by research in Biotechnology (5.1k citations), Immunology (3.0k citations), Oncology (3.0k citations), Physiology (381 citations) and Biomedical Engineering (3.2k citations). Richard Heller has collaborated with scholars based in United States, Slovenia and France. Frequent co-authors include Mark J. Jaroszeski, Loreé C. Heller, Richard Gilbert, Domenico Coppola, Richard Jove, Hua Yu, Ronald C. DeConti, M. L. Lucas, Drew M. Pardoll and Guilian Niu. Their work appears in journals such as Bioelectrochemistry, Gene Therapy, Molecular Therapy, Technology in Cancer Research & Treatment and Plasma Chemistry and Plasma Processing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.